Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,388 | 217 | 99.8% |
| Education | $19.91 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $4,234 | 71 | $0 (2023) |
| Amgen Inc. | $1,291 | 48 | $0 (2024) |
| Novo Nordisk Inc | $397.07 | 9 | $0 (2024) |
| Esperion Therapeutics, Inc. | $340.41 | 8 | $0 (2024) |
| Abbott Laboratories | $330.45 | 8 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $293.88 | 3 | $0 (2024) |
| Amarin Pharma Inc. | $237.32 | 8 | $0 (2021) |
| Aqua Pharmaceuticals | $184.07 | 15 | $0 (2017) |
| Lilly USA, LLC | $149.40 | 6 | $0 (2024) |
| PFIZER INC. | $145.71 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $986.66 | 23 | Abbott Laboratories ($307.46) |
| 2023 | $731.90 | 17 | Janssen Pharmaceuticals, Inc ($337.84) |
| 2022 | $501.22 | 13 | Janssen Pharmaceuticals, Inc ($226.00) |
| 2021 | $984.55 | 32 | Amgen Inc. ($371.60) |
| 2020 | $1,186 | 37 | Janssen Pharmaceuticals, Inc ($501.66) |
| 2019 | $2,230 | 58 | Janssen Pharmaceuticals, Inc ($1,413) |
| 2018 | $815.32 | 14 | Janssen Pharmaceuticals, Inc ($803.98) |
| 2017 | $972.36 | 27 | Janssen Pharmaceuticals, Inc ($749.56) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: Diabetes Care | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $85.42 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $135.44 | General |
| Category: Cardio-renal | ||||||
| 09/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Diabetes Care | ||||||
| 08/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $136.18 | General |
| Category: Cardio-renal | ||||||
| 07/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $68.85 | General |
| Category: Diabetes Care | ||||||
| 07/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $57.93 | General |
| Category: Diabetes Care | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Cardiology | ||||||
| 05/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $99.82 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $55.64 | General |
| Category: Diabetes Care | ||||||
| 03/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Inflammation | ||||||
| 02/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Diabetes | ||||||
| 01/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Inflammation | ||||||
| 01/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Biological | ||||||
| 11/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Diabetes | ||||||
| 10/13/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 667 | 1,087 | $375,483 | $86,821 |
| 2022 | 8 | 748 | 1,149 | $373,143 | $90,406 |
| 2021 | 7 | 745 | 1,234 | $398,413 | $102,243 |
| 2020 | 8 | 838 | 1,353 | $242,712 | $96,675 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 224 | 622 | $204,399 | $42,739 | 20.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 163 | 163 | $70,465 | $21,306 | 30.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 120 | 120 | $31,356 | $7,087 | 22.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2023 | 22 | 22 | $12,298 | $3,693 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 22 | 32 | $15,436 | $3,395 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 50 | $16,811 | $3,301 | 19.6% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2023 | 16 | 20 | $12,862 | $3,029 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 24 | 24 | $10,824 | $2,080 | 19.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 32 | 34 | $1,032 | $191.40 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 196 | 484 | $157,490 | $33,566 | 21.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 124 | 124 | $52,948 | $16,638 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 209 | $68,305 | $15,179 | 22.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 142 | 143 | $36,894 | $10,278 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $13,237 | $4,151 | 31.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 44 | 44 | $11,373 | $3,108 | 27.3% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2022 | 13 | 14 | $8,876 | $2,244 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 19 | $9,082 | $2,161 | 23.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Facility | 2022 | 11 | 11 | $4,785 | $1,518 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $7,168 | $1,265 | 17.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 38 | 39 | $2,145 | $216.63 | 10.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 14 | 15 | $840.00 | $81.42 | 9.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 185 | 524 | $169,745 | $38,474 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 251 | $81,407 | $18,559 | 22.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 101 | 101 | $41,939 | $13,862 | 33.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 116 | 116 | $29,928 | $9,017 | 30.1% |
About Phi Le
Phi Le is a Internal Medicine healthcare provider based in Ft Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568475200.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Phi Le has received a total of $8,408 in payments from pharmaceutical and medical device companies, with $986.66 received in 2024. These payments were reported across 221 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($8,388).
As a Medicare-enrolled provider, Le has provided services to 2,998 Medicare beneficiaries, totaling 4,823 services with total Medicare billing of $376,144. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Ft Lauderdale, FL
- Active Since 08/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1568475200
Products in Payments
- XARELTO (Drug) $2,668
- INVOKANA (Drug) $1,566
- Repatha (Biological) $536.45
- Otezla (Drug) $438.70
- Kerendia (Drug) $293.88
- FREESTYLE LIBRE 3 (Device) $251.82
- NEXLIZET (Drug) $242.79
- Vascepa (Drug) $237.32
- Aimovig (Biological) $218.00
- MOUNJARO (Drug) $134.83
- Wegovy (Drug) $124.99
- FFRct (Device) $119.06
- Ozempic (Drug) $100.98
- Altabax (Drug) $98.97
- FARXIGA (Drug) $98.67
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $98.00
- NEXLETOL (Drug) $97.62
- EVENITY (Biological) $86.48
- CARTO 3 (Device) $59.33
- FREESTYLE LIBRE (Device) $55.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ft Lauderdale
Dr. Alexey Sorokin, Md, MD
Internal Medicine — Payments: $42,981
Daniel Weitz, M.d, M.D
Internal Medicine — Payments: $29,875
James Luckett, Md, MD
Internal Medicine — Payments: $10,996
Dr. Caren Singer, Md, MD
Internal Medicine — Payments: $10,409
Jorge Flores
Internal Medicine — Payments: $7,807
Dr. Barbara Scherer, Md, MD
Internal Medicine — Payments: $7,663